• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MERZ NORTH AMERICA, INC COAPTITE INJECTABLE IMPLANT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MERZ NORTH AMERICA, INC COAPTITE INJECTABLE IMPLANT Back to Search Results
Catalog Number 8005P10
Device Problem Insufficient Information (3190)
Patient Problem Micturition Urgency (1871)
Event Date 12/20/2013
Event Type  Other  
Event Description
A pt, (b)(6) was enrolled in the (b)(4) study for stress urinary incontinence.The pt was injected with 2.0 ml of coaptite lot 31031982 on (b)(6) 2012.On (b)(6) 2013, the pt reported urinary urgency.On (b)(6) 2013, a straight catheterization was performed.The problem ws resolved by (b)(6) 2013.Other medical history: on (b)(6) 2012, the pt had idiopathic chronic eosinophilic pneumonia and was hospitalized until (b)(6) 2012.On (b)(6) 2012 an ekg, cxr (chest x-ray), and echocardiogram were done and meds were given including bronchodilators.On (b)(6) 2012, a ct of the chest was done.On (b)(6) 2012, a bronchoscopy was done.On (b)(6) 2012, prednisone was given.On (b)(6) 2013, cxr and labs were done.Singulair was started.On (b)(6) 2013, a cxr was done.On (b)(6) 2013, allergy testing was done.On (b)(6) 2013, celebrex was discontinued.On (b)(6) 2013, a cxr and pulmonary function test was done.
 
Manufacturer Narrative
On (b)(6) 2013, a ct of the chest was done.On (b)(6) 2013, a pulmonary function testing (pft) was done.On (b)(6) 2013, a cxr and pft were done.On (b)(6) 2013, zyrtec, flonase and albuterol were added.On (b)(6) 2013, a cxr and pft were done.On (b)(6) 2013, a cxr and pft were done.The event of idiopathic chronic eosinophilic pneumonia was assessed by the physician as mild in severity and definitely not device related.On (b)(6) 2013, the pt had intermittent actinic keratoses.A physical exam was done by a physician and the pt was treated with a double freeze/thaw cycle.On (b)(6) 2013, a liquid nitrogen therapy was done.Also on (b)(6) 2013, intermittent seborrheic keratoses were noted, but not treated.The physician assessed both keratoses as mild in severity and definitely not device related.On (b)(6) 2013, the pt had a right lower extremity rash and was seen by a dermatologist.The physician noted that it is likely pretibial pruritic papular dermatitis.Koh scraping was performed.Negative for hyphae.The physician prescribed triamcinolone 0.17 cream two times a day, apply topically.The physician assessed the event as mild in severity and definitely not device related.On (b)(6) 2013, the pt had intermittent (b)(6) and was seen by a dermatologist.On (b)(6) 2013, the pt was put on a 5 day course of acyclovir 400mg by mouth 3 times a day.The physician assessed the event as mild in severity and definitely not device related.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
COAPTITE INJECTABLE IMPLANT
Type of Device
INJECTABLE IMPLANT
Manufacturer (Section D)
MERZ NORTH AMERICA, INC
franksville WI
Manufacturer Contact
ann metz
4133 courtney road, #10
franksville, WI 53126
2628353300
MDR Report Key4223997
MDR Text Key19722288
Report Number2135225-2014-00084
Device Sequence Number1
Product Code LNM
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P040047
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Study,Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial
Report Date 10/01/2014
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date04/01/2015
Device Catalogue Number8005P10
Device Lot Number1031982
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 10/01/2014
Initial Date FDA Received10/29/2014
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured04/01/2012
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
DETROL LA 4MG
Patient Outcome(s) Required Intervention;
Patient Age78 YR
Patient Weight96
-
-